Euglena Co Ltd (2931)

Currency in JPY
333.0
+1.0(+0.30%)
Delayed Data·
Earnings results expected tomorrow
2931 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
333.0338.0
52 wk Range
318.0513.0
Key Statistics
Bid/Ask
333.00 / 334.00
Prev. Close
332
Open
333
Day's Range
333-338
52 wk Range
318-513
Volume
363.5K
Average Volume (3m)
935.58K
1-Year Change
-33.7945%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2931 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
400.0
Upside
+20.12%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 400.0
(+20.12% Upside)

Earnings

Latest Release
May 14, 2026
EPS / Forecast
-0.23 / --
Revenue / Forecast
13.2B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -2.41%
Dividend Yield
0.60%
Industry Median 2.47%
Annualized payout
2.00
Paid unevenly
5-Years Growth
-
Growth Streak

2931 Income Statement

Compare 2931 to Peers and Sector

Metrics to compare
2931
Peers
Sector
Relationship
P/E Ratio
−140.3x21.8x11.7x
PEG Ratio
−2.060.110.03
Price/Book
1.4x1.7x1.5x
Price / LTM Sales
0.9x1.3x0.9x
Upside (Analyst Target)
20.5%1.6%24.3%
Fair Value Upside
Unlock9.6%13.9%Unlock

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and social businesses; and invests in biotechnology related businesses. Further, the company provides genome analysis services. Euglena Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.

Employees
793
Market
Japan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
17.30M12.40%5.83B
Other Institutional Investors
12.74M9.13%4.29B
Public Companies & Retail Investors
109.46M78.46%36.89B
Total
139.5M100.00%47.01B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Kirei Sozo Holdings Co., Ltd.7.82%10,914,1253,678,060
NEXT FUNDS TOPIX Exchange Traded Fund2.91%4,058,5001,367,715

People Also Watch

2,448.0
6965
-4.00%
4,607.0
6963
-2.99%
4,604.0
5803
-9.25%
2,639.0
7013
-1.95%
1,888.0
7272
+4.60%

FAQ

What Is the Euglena Co Ltd (2931) Stock Price Today?

The Euglena Co Ltd stock price today is 333.0 JPY.

What Stock Exchange Does Euglena Co Ltd Trade On?

Euglena Co Ltd is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for Euglena Co Ltd?

The stock symbol for Euglena Co Ltd is "2931."

Does Euglena Co Ltd Pay Dividends? What’s The Current Dividend Yield?

The Euglena Co Ltd dividend yield is 0.6%.

What Is the Euglena Co Ltd Market Cap?

As of today, Euglena Co Ltd market cap is 46.59B JPY.

What Is Euglena Co Ltd's Earnings Per Share (TTM)?

The Euglena Co Ltd EPS (TTM) is -2.4.

When Is the Next Euglena Co Ltd Earnings Date?

Euglena Co Ltd will release its next earnings report on Aug 07, 2026.

From a Technical Analysis Perspective, Is 2931 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Euglena Co Ltd Stock Split?

Euglena Co Ltd has split 2 times.

How Many Employees Does Euglena Co Ltd Have?

Euglena Co Ltd has 793 employees.

What is the current trading status of Euglena Co Ltd (2931)?

As of Aug 06, 2026, Euglena Co Ltd (2931) is trading at a price of 333.0 JPY, with a previous close of 332.0 JPY. The stock has fluctuated within a day range of 333.0 JPY to 338.0 JPY, while its 52-week range spans from 318.0 JPY to 513.0 JPY.

What Is Euglena Co Ltd (2931) Price Target According to Analysts?

The average 12-month price target for Euglena Co Ltd is 400.0 JPY, with a high estimate of 400 JPY and a low estimate of 400 JPY. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +20.12% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.